Choosing an equivalence limit for noninferiority or equivalence studies
- 1 February 2002
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 23 (1) , 2-14
- https://doi.org/10.1016/s0197-2456(01)00196-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Choice of Delta in Equivalence TestingDrug Information Journal, 2001
- Testing Noninferiority of Response Rates for Regulatory Filings Using TransformationsDrug Information Journal, 2001
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001
- ON TESTING EQUIVALENCE OF THREE POPULATIONSJournal of Biopharmaceutical Statistics, 1999
- Design Issues in Noninferiority/Equivalence TrialsDrug Information Journal, 1999
- Clinical Equivalence—A ClarificationDrug Information Journal, 1999
- Can we reduce the dose of a vaccine?Controlled Clinical Trials, 1997
- Problems in interpreting active control equivalence trialsAccountability in Research, 1996
- Determining equivalence and the impact of sample size in anti-infective studies: a point to considerJournal of Biopharmaceutical Statistics, 1996
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987